News
GLP-1 Receptor Agonists Linked to Lower Mortality for Patients With Brain Metastases, T2 DM
3+ week, 5+ day ago (292+ words) All-cause mortality significantly lower with GLP-1 RA use, with consistent benefit across major cancer types, most GLP-1 RA types. (Health Day News) " For patients with cancer and brain metastases (BM) and type 2 diabetes (T2 D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use…...
New Model Improves Prognosis Prediction in HMA-Treated MDS
2+ day, 21+ hour ago (168+ words) In a large global retrospective analysis, IPSS-M provided no meaningful improvement in prognostic discrimination over IPSS-R, whereas a model integrating clinical characteristics and selected mutations achieved stronger predictive performance and supported the development of an online clinical tool. Investigators analyzed…...
Bone Pain Reduced With Pegfilgrastim Administration 72 Hours After Chemo
6+ day, 21+ hour ago (353+ words) Lower rates of severe bone pain incidence seen for the 72-hour group versus 24- and 48-hour groups. (Health Day News) " For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 hours,…...
AI to predict how bowel cancer patients will respond to new NHS drug
1+ hour, 25+ min ago (398+ words) Phen Map tool could spare thousands of patients from treatment that would be ineffective for them A new AI-driven way of identifying how patients with advanced bowel cancer will respond to a drug that was recently introduced by the NHS…...
'It's incredible, like science fiction': How a new wave of immunotherapy is eliminating cancers
8+ hour, 13+ min ago (1092+ words) After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age " and saving patient's lives. When 71-year-old Maureen Sideris was treated for colon cancer in 2008, she had to go under the knife....
Molecular Vulnerabilities in Fusion-Driven Neoplasms: Integrating Diagnostic Markers and Preclinical Drug Discovery
3+ day, 6+ hour ago (288+ words) Structural alterations in the genome, particularly those leading to fusion oncogenes, represent cornerstone events in the biology of both solid and hematolog. .. You will be redirected to our submission process. About this Research Topic Manuscript Submission Deadline 26 October 2026 This Research…...
Colorectal Cancer Deaths Rising in Young Adults and Minority Communities
1+ mon, 4+ day ago (1121+ words) (News USA) - Expanded Coverage for Less-Invasive Tests Can Help Colorectal cancer is now the top cause of cancer deaths in men and women 50 and younger. Deaths from other common cancers in younger adults are dropping, but this one is rising....
New Sarawak cancer hospital aims to serve patients across Borneo; design complete, tender next
1+ day, 1+ hour ago (467+ words) KUCHING, April 12 " The proposed Sarawak Cancer Centre is expected to commence construction in 2027 following the completion of its design phase, said Deputy Health Minister Datuk Hanifah Hajar Taib. She said the project has already completed its design stage and is…...
bio M'rieux Unveils its BIOFIRE" SPOTFIRE" Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
4+ day, 3+ hour ago (113+ words) ABOUT BIOM'RIEUXPioneering Diagnostics A world leader in the field of in'vitro diagnostics since 1963, bio M'rieux is present in 45'countries and serves more than 160'countries with the support of a large network of distributors. In 2025, revenues reached "4. 1 billion, with over 94% of…...
OS Therapies Announces FDA OST-HER2 Type D Meeting Elevated to Type B Pre-BLA Meeting
1+ mon, 2+ day ago (736+ words) We credit FDA with taking decisive action to help advance Accelerated Approval discussions regarding OST-HER2 for pediatric cancer patients with osteosarcoma." " Paul Romness, MPH, Chairman & CEO of. .. OS Therapies Announces FDA OST-HER2 Type D Meeting Elevated to Type B Pre-BLA…...